Hyperkalemia and the Use of New Potassium Binders a Single Center Experience from Vestfold Norway (The PotBind Study).
Thea BjuneThea Bjerkestrand BøeStig Arne KjellevoldKristian HeldalSadollah AbediniPublished in: International journal of nephrology and renovascular disease (2023)
New potassium binders in clinical practice are an easy and safe treatment with few side effects and good tolerance, that significantly lowers the risk of hyperkalemia. Furthermore, and most importantly, patients can be maintained on RAASi treatment.